ProfileGDS5822 / ILMN_2851023
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 84% 83% 79% 85% 83% 83% 84% 83% 83% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 1212.284
GSM1276600PDAC Late Ablation Control 2210.483
GSM1276601PDAC Late Ablation Control 3184.979
GSM1276602PDAC Late Ablation 1240.585
GSM1276603PDAC Late Ablation 2210.483
GSM1276604PDAC Late Ablation 3226.683
GSM1303940PDAC Late Ablation_anti-CTLA4 1206.784
GSM1303941PDAC Late Ablation_anti-CTLA4 2250.683
GSM1303942PDAC Late Ablation_anti-CTLA4 3246.283